Is There a Need to Alter the Timing of Anti-Müllerian Hormone Measurement During the Menstrual Cycle?
- PMID: 31303661
- PMCID: PMC6620182
- DOI: 10.1055/a-0840-3817
Is There a Need to Alter the Timing of Anti-Müllerian Hormone Measurement During the Menstrual Cycle?
Abstract
Introduction There are numerous conflicting studies which have addressed the question whether the measurement of anti-Müllerian hormone (AMH) concentrations should be done at a certain time during the menstrual cycle. We aimed to investigate AMH fluctuations during the follicular and luteal phases of the menstrual cycle and to determine whether AMH variations, if present, might influence the clinical utility of ovarian reserve markers. Materials and Methods A total of 257 infertile women eligible for inclusion were categorized into three groups based on their total antral follicle count: 1. hypo-response group (< 7 follicles, n = 66), 2. normo-response group (7 - 19 follicles, n = 98), and 3. hyper-response group (> 19 follicles, n = 93). Results Mean follicular AMH levels were elevated compared to levels in the luteal phase in all response groups (p < 0.001). There were significant and strong positive correlations between follicular and luteal AMH levels in all response groups (Spearman's r = 0.822, r = 0.836, and r = 0.899, respectively; p < 0.001 for all groups). Fisher's Z-test comparisons of these correlations in all response groups demonstrated that there was no statistically significant difference (Z = 0.277, Z = - 1.001, and Z = - 1.425, respectively; p < 0.001). Conclusion We found that serum AMH levels in the follicular phase were higher than those in the luteal phase in all three response groups. In current practice, fluctuations in serum AMH concentrations are not large enough to alter the timing of AMH measurements during the menstrual cycle. The issue is important for the assessment of ovarian reserve in infertile women with AMH levels near to the cut-off value.
Einleitung Es gibt zahlreiche widersprüchliche Studien, die sich der Frage widmen, ob die Messung des Anti-Müller-Hormon-(AMH-)Spiegels an einem bestimmten Zeitpunkt im Menstruationszyklus durchgeführt werden sollte. Ziel dieser Studie war es, Fluktuationen des Anti-Müller-Hormon-Spiegels während der Follikelphase und der Lutealphase des Menstruationszykluses zu messen, auch um zu bestimmen, ob Fluktuationen des AMH-Spiegels, falls es sie gibt, den klinischen Nutzen als Marker der ovariellen Reserve beeinflussen könnten. Material und Methoden Insgesamt 257 unfruchtbare Frauen, welche die Einschlusskriterien erfüllten, wurden in die Studien eingeschlossen und in 3 Reaktionsgruppen eingeteilt. Die Einteilung beruhte auf der jeweiligen Gesamtzahl antraler Follikel, wie folgt: 1. Hypo-Gruppe (< 7 Follikel, n = 66), 2. Normalgruppe (7 – 19 Follikel, n = 98), und 3. Hyper-Gruppe (> 19 Follikel, n = 93). Ergebnisse Verglichen mit der Lutealphase war der durchschnittliche AMH-Spiegel während der Follikelphase in allen 3 Gruppen erhöht (p < 0,001). Es gab eine signifikante und starke positive Korrelation zwischen dem AMH-Spiegel in der Follikelphase und dem AMH-Spiegel in der Lutealphase bei allen Gruppen (Korrelationskoeffizient nach Spearman r = 0,822, r = 0,836 bzw. r = 0,899; p < 0,001 für alle Gruppen). Der Vergleich dieser Korrelationen mithilfe des Fisher-z-Tests zeigte, dass es in keiner der Gruppen einen statistisch signifikanten Unterschied gab (z = 0,277, z = − 1,001 bzw. z = − 1,425; p < 0,001). Schlussfolgerung Es stellte sich heraus, dass in allen 3 Gruppen der AMH-Spiegel in der Follikelphase höher war als der AMH-Spiegel in der Lutealphase. Die Flukutationen des AMH-Spiegels sind jedoch nicht hoch genug, um den Zeitpunkt der AMH-Messung während des Menstruationszyklus in der aktuellen klinischen Praxis zu ändern. Dieses Thema ist aber für die Evaluierung der ovariellen Reserve von unfruchtbaren Frauen mit AMH-Spiegeln, die nahe beim Cut-off-Wert sind, von Bedeutung.
Keywords: AMH; Anti-Müllerian hormone; fluctuation; measurement; ovarian reserve; variation.
Conflict of interest statement
Similar articles
-
Anti-Müllerian hormone exhibits a great variation in infertile women with different ovarian reserve patterns.Aust N Z J Obstet Gynaecol. 2017 Aug;57(4):464-468. doi: 10.1111/ajo.12625. Epub 2017 Apr 17. Aust N Z J Obstet Gynaecol. 2017. PMID: 28419409
-
Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates.Hum Reprod. 2016 Jul;31(7):1522-30. doi: 10.1093/humrep/dew100. Epub 2016 May 9. Hum Reprod. 2016. PMID: 27165618 Free PMC article.
-
The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.Hum Reprod. 2017 Jan;32(1):208-214. doi: 10.1093/humrep/dew304. Epub 2016 Dec 6. Hum Reprod. 2017. PMID: 27927849
-
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).Hum Reprod Update. 2010 Mar-Apr;16(2):113-30. doi: 10.1093/humupd/dmp036. Epub 2009 Sep 30. Hum Reprod Update. 2010. PMID: 19793843 Review.
-
The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling.Acta Obstet Gynecol Scand. 2018 Sep;97(9):1105-1113. doi: 10.1111/aogs.13334. Epub 2018 Mar 30. Acta Obstet Gynecol Scand. 2018. PMID: 29476703 Review.
Cited by
-
Does Anti-Müllerian hormone vary during a menstrual cycle? A systematic review and meta-analysis.J Ovarian Res. 2022 Jul 1;15(1):78. doi: 10.1186/s13048-022-01006-z. J Ovarian Res. 2022. PMID: 35778760 Free PMC article.
-
Predictive value of anti-Mullerian hormone for pregnancy outcomes following assisted reproductive techniques (ART) in Southwest China.Reprod Health. 2022 Dec 13;19(1):224. doi: 10.1186/s12978-022-01524-5. Reprod Health. 2022. PMID: 36514055 Free PMC article.
-
The pregnancy outcomes among women receiving individualized algorithm dosing with follitropin delta: a systematic review of randomized controlled trials.J Assist Reprod Genet. 2024 Jul;41(7):1851-1861. doi: 10.1007/s10815-024-03146-1. Epub 2024 May 29. J Assist Reprod Genet. 2024. PMID: 38809330 Free PMC article.
-
Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS.Int J Mol Sci. 2021 Nov 19;22(22):12507. doi: 10.3390/ijms222212507. Int J Mol Sci. 2021. PMID: 34830389 Free PMC article. Review.
-
Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary Syndrome.Biomedicines. 2023 Nov 27;11(12):3150. doi: 10.3390/biomedicines11123150. Biomedicines. 2023. PMID: 38137371 Free PMC article.
References
-
- Broer S L, Mol B W, Hendriks D. The role of anti-Mullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705–714. - PubMed
-
- Broekmans F J, de Ziegler D, Howles C M. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94:1044–1051. - PubMed
-
- Iliodromiti S, Anderson R A, Nelson S M. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update. 2015;21:698–710. - PubMed
LinkOut - more resources
Full Text Sources